Search research articles
Contact Us
Filters
Showing results (601-610 of 654) with videos related to
Page
of 66
Sort By:
Cytotherapy
|
August 13, 2002
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation
P D Kottaridis, D W Milligan, R Chopra, et al.
Journal of Medicinal Chemistry
|
September 27, 2008
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models
Marlon D Cowart, Robert J Altenbach, Huaqing Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 6, 2005
Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists
Anil Vasudevan, Andrew J Souers, Jennifer C Freeman, et al.
Blood
|
September 26, 2000
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
P D Kottaridis, D W Milligan, R Chopra, et al.
Journal of Medicinal Chemistry
|
November 6, 2008
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia
Huaqing Liu, Robert J Altenbach, Tracy L Carr, et al.
Journal of Medicinal Chemistry
|
January 19, 1996
A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease
H L Sham, C Zhao, K D Stewart, et al.
Bioorganic & Medicinal Chemistry
|
May 26, 2012
Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²⁺ channel blockers with analgesic activity
Xenia Beebe, Daria Darczak, Rodger F Henry, et al.
Journal of Medicinal Chemistry
|
June 23, 2007
In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonists
Richard J Perner, Stanley DiDomenico, John R Koenig, et al.
British Journal of Pharmacology
|
May 6, 2009
In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties
M I Strakhova, C A Cuff, A M Manelli, et al.
Journal of Medicinal Chemistry
|
June 10, 2005
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors
Clarence J Maring, Vincent S Stoll, Chen Zhao, et al.
Page
of 66
Search research articles
Search
Showing results (601-610 of 654) with videos related to
Sort By:
Page
of 66
Cytotherapy
|
August 13, 2002
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation
P D Kottaridis, D W Milligan, R Chopra, et al.
Journal of Medicinal Chemistry
|
September 27, 2008
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models
Marlon D Cowart, Robert J Altenbach, Huaqing Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 6, 2005
Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists
Anil Vasudevan, Andrew J Souers, Jennifer C Freeman, et al.
Blood
|
September 26, 2000
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
P D Kottaridis, D W Milligan, R Chopra, et al.
Journal of Medicinal Chemistry
|
November 6, 2008
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia
Huaqing Liu, Robert J Altenbach, Tracy L Carr, et al.
Journal of Medicinal Chemistry
|
January 19, 1996
A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease
H L Sham, C Zhao, K D Stewart, et al.
Bioorganic & Medicinal Chemistry
|
May 26, 2012
Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²⁺ channel blockers with analgesic activity
Xenia Beebe, Daria Darczak, Rodger F Henry, et al.
Journal of Medicinal Chemistry
|
June 23, 2007
In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonists
Richard J Perner, Stanley DiDomenico, John R Koenig, et al.
British Journal of Pharmacology
|
May 6, 2009
In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties
M I Strakhova, C A Cuff, A M Manelli, et al.
Journal of Medicinal Chemistry
|
June 10, 2005
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors
Clarence J Maring, Vincent S Stoll, Chen Zhao, et al.
Page
of 66